Meridian Bioscience's Q2 Revenues Increase 30% To $111M, Highest In Company History

  • Meridian Bioscience Inc VIVO reported a 30% increase in Q2 sales to $111.2 million, the highest in the company's history, with both segments ahead of expectations, beating the consensus of $99.54 million.
  • Revenues from the life science division grew 32% Y/Y to $70.1 million. Diagnostic segment sales rose 29% to $41.1 million.
  • Within diagnostics, molecular assay revenues were flat at $4.4 million. Non-molecular assay revenues climbed 33% to $36.7 million.
  • In the life sciences division, revenues from molecular reagents were $40.3 million, up 7%, and revenues from immunological reagents were $29.8 million, up 91%. 
  • The company said that the product mix shifted away from molecular reagents to immunological reagents due to higher demand for COVID-19 rapid antigen tests.
  • Adjusted EPS was $0.66, ahead of the consensus of $0.47 and $0.56 a year ago.
  • The company finished the quarter with cash and cash equivalents of $76.5 million.
  • Guidance: Meridian raised FY22 sales guidance to $330 million - $345 million (consensus $337.62 million), better than the previous guidance of $315 million - $330 million.
  • The guidance includes life science revenues of $185 million - $195 million, vs. the prior range of $170 million - $180 million.
  • Diagnostics revenue guidance remains unchanged at between $145 million - $150 million. 
  • The company expects an adjusted EPS of $1.30 - $1.40 (consensus $1.37) versus the earlier outlook of $1.10 - $1.30.
  • This guidance anticipates that life sciences revenues will drop in the second half of the year as demand decreases for reagents used in COVID-19 tests.
  • Price Action: VIVO shares are down 2.99% at $25.82 during the market session on the last check Friday.

Posted In: BriefsEarningsNewsGuidanceHealth CareSmall CapMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.